OBJECTIVE: To test the hypothesis that patients with multiple sclerosis (MS) with intereye asymmetry on low contrast letter acuity, and thickness of the retinal nerve fiber layer (RNFL), would exhibit corresponding changes in cortical timing and amplitude responses on pattern reversal multifocal visual evoked potentials (mfVEP), contingent upon variable stimulus contrast. METHODS: In a cross-sectional study, we investigated a cohort of 11 normal subjects and 40 patients with MS, 21 of whom had a history of acute optic neuritis (MS-AON) with an intereye asymmetry with respect to RNFL thickness, and on low contrast letter acuity performance. Pattern reversal mfVEP was performed at high (100%), low (33.3%), and very low (14.2%) Michelson-contrast levels. RESULTS: Compared to baseline measures at 100% contrast, the mean amplitude of the mfVEP was reduced in MS-AON eyes, upon pattern-reversal stimulation at the 2 lower contrast levels (p < 0.0001). With respect to changes in timing responses, the intereye asymmetry was increased in the MS-AON patients upon lower contrast pattern-reversal stimulation (p < 0.0001 for 33.3% compared to 100%, and p < 0.001 for 14.2% compared to 100%). The fellow eye in 12 (57%; p < 0.001) of the patients with an abnormal eye, and a history of AON, revealed abnormal amplitude and timing responses upon low contrast stimulation (signifying unmasking of occult damage). CONCLUSIONS: Our findings support the hypothesis that mfVEP metric abnormalities are contingent upon contrast magnitude during pattern reversal stimulation. Further, this paradigm was capable of unmasking occult abnormalities in a significant number of apparently unaffected eyes.
OBJECTIVE: To test the hypothesis that patients with multiple sclerosis (MS) with intereye asymmetry on low contrast letter acuity, and thickness of the retinal nerve fiber layer (RNFL), would exhibit corresponding changes in cortical timing and amplitude responses on pattern reversal multifocal visual evoked potentials (mfVEP), contingent upon variable stimulus contrast. METHODS: In a cross-sectional study, we investigated a cohort of 11 normal subjects and 40 patients with MS, 21 of whom had a history of acute optic neuritis (MS-AON) with an intereye asymmetry with respect to RNFL thickness, and on low contrast letter acuity performance. Pattern reversal mfVEP was performed at high (100%), low (33.3%), and very low (14.2%) Michelson-contrast levels. RESULTS: Compared to baseline measures at 100% contrast, the mean amplitude of the mfVEP was reduced in MS-AON eyes, upon pattern-reversal stimulation at the 2 lower contrast levels (p < 0.0001). With respect to changes in timing responses, the intereye asymmetry was increased in the MS-AON patients upon lower contrast pattern-reversal stimulation (p < 0.0001 for 33.3% compared to 100%, and p < 0.001 for 14.2% compared to 100%). The fellow eye in 12 (57%; p < 0.001) of the patients with an abnormal eye, and a history of AON, revealed abnormal amplitude and timing responses upon low contrast stimulation (signifying unmasking of occult damage). CONCLUSIONS: Our findings support the hypothesis that mfVEP metric abnormalities are contingent upon contrast magnitude during pattern reversal stimulation. Further, this paradigm was capable of unmasking occult abnormalities in a significant number of apparently unaffected eyes.
Authors: Alexander Klistorner; Stuart Graham; Clare Fraser; Raymond Garrick; Tan Nguyen; Michael Paine; Justin O'Day; John Grigg; Hemamalini Arvind; Frank A Billson Journal: Invest Ophthalmol Vis Sci Date: 2007-10 Impact factor: 4.799
Authors: Elliot M Frohman; James G Fujimoto; Teresa C Frohman; Peter A Calabresi; Gary Cutter; Laura J Balcer Journal: Nat Clin Pract Neurol Date: 2008-12
Authors: Alexander Klistorner; Hemamalini Arvind; Raymond Garrick; Stuart L Graham; Mark Paine; Con Yiannikas Journal: Invest Ophthalmol Vis Sci Date: 2009-12-30 Impact factor: 4.799
Authors: Jennifer B Fisher; Dina A Jacobs; Clyde E Markowitz; Steven L Galetta; Nicholas J Volpe; M Ligia Nano-Schiavi; Monika L Baier; Elliot M Frohman; Heather Winslow; Teresa C Frohman; Peter A Calabresi; Maureen G Maguire; Gary R Cutter; Laura J Balcer Journal: Ophthalmology Date: 2006-01-10 Impact factor: 12.079
Authors: Fiona Costello; Stuart Coupland; William Hodge; Gianni R Lorello; Jeannie Koroluk; Y Irene Pan; Mark S Freedman; David H Zackon; Randy H Kardon Journal: Ann Neurol Date: 2006-06 Impact factor: 10.422
Authors: Alexander Klistorner; H Arvind; T Nguyen; R Garrick; M Paine; S Graham; J O'Day; C Yiannikas Journal: Doc Ophthalmol Date: 2008-09-09 Impact factor: 2.379
Authors: Zane S Schnurman; Teresa C Frohman; Shin C Beh; Darrel Conger; Amy Conger; Shiv Saidha; Steven Galetta; Peter A Calabresi; Ari J Green; Laura J Balcer; Elliot M Frohman Journal: Neurology Date: 2014-04-30 Impact factor: 9.910
Authors: Ethan Meltzer; Peter V Sguigna; Adnan Subei; Shin Beh; Eric Kildebeck; Darrel Conger; Amy Conger; Marlen Lucero; Benjamin S Frohman; Ashley N Frohman; Shiv Saidha; Steven Galetta; Peter A Calabresi; Robert Rennaker; Teresa C Frohman; Randy H Kardon; Laura J Balcer; Elliot M Frohman Journal: JAMA Neurol Date: 2017-05-01 Impact factor: 18.302
Authors: Jeffrey L Bennett; Molly Nickerson; Fiona Costello; Robert C Sergott; Jonathan C Calkwood; Steven L Galetta; Laura J Balcer; Clyde E Markowitz; Timothy Vartanian; Mark Morrow; Mark L Moster; Andrew W Taylor; Thaddeus W W Pace; Teresa Frohman; Elliot M Frohman Journal: J Neurol Neurosurg Psychiatry Date: 2014-10-29 Impact factor: 10.154
Authors: Laura J Balcer; Jenelle Raynowska; Rachel Nolan; Steven L Galetta; Raju Kapoor; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn Hudson; Richard Rudick Journal: Mult Scler Date: 2017-02-16 Impact factor: 6.312
Authors: Martin Hardmeier; Florian Hatz; Yvonne Naegelin; Darren Hight; Christian Schindler; Ludwig Kappos; Margitta Seeck; Christoph M Michel; Peter Fuhr Journal: Brain Topogr Date: 2013-10-02 Impact factor: 3.020